Health and Healthcare
Health and Healthcare Articles
Principia Biopharma shares jumped to start out the week after it was announced that it would be acquired by Sanofi.
Published:
These are five biotech and medtech stocks for very aggressive accounts that look to get shares count leverage on companies that have sizable upside potential.
Published:
CureVac stock exploded into the market, more than double its original pricing. Since then, it is up more or less triple its original pricing.
Published:
Taiwan Liposome Co. Ltd (NASDAQ: TLC) shares shot higher on Friday after the company announced it was making a regulatory filing for a COVID-19 treatment that has been at the center of some...
Published:
New York State may rank fourth in COVID-19 confirmed case count, but its death toll is well over twice that of any other state in the country.
Published:
There are several academic models of how many Americans will die of COVID-19 this year. One puts the number at well over 500,000.
Published:
When Moderna announced a new deal with the U.S. government for its COVID-19 vaccine, it appeared be a case of “sell the news,” because this is ultimately a net positive for the company.
Published:
Royalty Pharma reported quarterly results on Wednesday morning that were boosted by Imbruvica and the addition of new royalties.
Published:
The July 31 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
Eyenovia shares soared on Tuesday after the company announced an exclusive license agreement with Artic Vision.
Published:
24/7 Wall St. has compiled a list of some speculative biotech plays that could see gains of up to 300% in the coming months.
Published:
Seres Therapeutics shares more than tripled early on Monday after the firm announced positive late-stage results for its C. difficile infection study.
Published:
AnPac Bio-Medical Science shares surged higher on Friday after the company reaffirmed its status as a COVID-19 stock.
Published:
The world may be focused on COVID-19 this year, but the battle against Alzheimer’s disease continues with no effective treatments. Biogen hopes to remedy that unfortunate situation.
Published:
Denali Therapeutics announced early Thursday that it would be progressing its Parkinson’s treatment into late-stage studies in collaboration with Biogen.
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.